Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
| Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
|---|---|---|---|---|---|
| Molecular Partners Ag | LSE:0QXX | London | Ordinary Share | CH0256379097 | MOLECULAR PARTNERS ORD SHS |
| Price Change | % Change | Share Price | Bid Price | Offer Price | |
|---|---|---|---|---|---|
| 0.00 | 0.00% | 25.20 |
| High Price | Low Price | Open Price | Shares Traded | Last Trade |
|---|---|---|---|---|
| 113 | 00:00:00 |
| Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
|---|---|---|---|---|---|
| Pharmaceutical Preparations | 7.04M | -61.98M | -1.7050 | -14.78 | 916.12M |
| Date | Time | Source | Headline |
|---|---|---|---|
| 07/11/2024 | 21:00 | UKREG | Molecular Partners Presents Preclinical Proof-of-Concept for CD3.. |
| 05/11/2024 | 21:00 | UKREG | Molecular Partners Announces Upcoming Poster Presentations at the 65th ASH.. |
| 31/10/2024 | 20:00 | UKREG | Molecular Partners Q3 2024 Interim Management Statement: Multiple Updates.. |
| 25/10/2024 | 05:00 | UKREG | Molecular Partners Announces Pricing of $20 Million Underwritten Offering |
| 22/10/2024 | 05:00 | UKREG | Molecular Partners and Orano Med Strengthen Agreement to Co-Develop.. |
| 22/10/2024 | 05:00 | UKREG | Molecular Partners and Orano Med Present Additional Positive Preclinical.. |
| 04/10/2024 | 05:00 | UKREG | Molecular Partners Announces upcoming poster presentations at the 2024 SITC.. |
| 27/9/2024 | 05:00 | UKREG | Molecular Partners Announces Upcoming Top-Rated Oral Presentation on.. |
| 26/8/2024 | 20:00 | UKREG | Molecular Partners Reports H1 2024 Corporate Highlights and Financials |
| 14/6/2024 | 05:00 | UKREG | Molecular Partners Presents Positive Preclinical Data for First.. |
1 Year Molecular Partners Chart |
Intraday Molecular Partners Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
